Rapamycin extends life in mice through mechanisms similar to those of calorie restriction, but has serious side-effects - though researchers are working to separate the positive mechanisms from the undesirable negative mechanisms. Metformin is also thought to be a calorie restriction mimetic drug, but the evidence for it to extend life in mice is mixed. Here, researchers suggest trying both drugs at the same time in the hopes that metformin blunts some of the side-effects of rapamycin: "Treatment with rapamycin, an inhibitor of mammalian target of rapamycin complex 1 (mTORC1) can increase mammalian life span. However, extended treatment with rapamycin results in increased hepatic gluconeogenesis concomitant with glucose and insulin insensitivity through inhibition of mTOR complex 2 (C2). Genetic studies show that increased life span associated with mTORC1 inhibition can be at least partially decoupled from increased gluconeogenesis associated with mTORC2 inhibition. Adenosine monophosphate kinase (AMPK) agonists such as metformin, which inhibits gluconeogenesis, [might] be expected to block the glucose dysmetabolism mediated by rapamycin."
First Steps
- Read an Introduction to Living Longer
- Read the Fight Aging! FAQ
- Help Researchers Extend Healthy Life
- Sign up for the Fight Aging! Newsletter
The Causes of Aging
- Accumulating AGEs
- Buildup of Amyloid Between Cells
- The Failing Adaptive Immune System
- The Failing Innate Immune System
- Declining Lysosomal Function
- Mitochondrial DNA Damage
- Nuclear DNA Damage
- Buildup of Senescent Cells
- Other Causes of Aging
Archives and Feeds
- Monthly News and Blog Archives
- Newsletter Archive
- Using the Fight Aging! Content Feeds
- Fight Aging! on the Kindle
Required Reading
- Calorie Restriction
- The Community, Visualized
- Cryonics
- Enthusiasm for the Slow Road
- Envisaging a World Without the FDA
- How to Argue for Longevity Science
- The Odds of Human Longevity Mutations
- The Need For Activism and Advocacy
- SENS: Engineered Negligible Senescence
- Stem Cells, Regenerative Medicine
- The Three Types of Aging Research
- Twelve Ways to Extend Mouse Life Span
- Transhumanism and Human Longevity
- What is Anti-Aging?
- Why Prioritize SENS Research?
Creative Commons
- All of Fight Aging!, with the exception of the introductory articles, is published under the Creative Commons Attribution 3.0 license. In short, this means that you are encouraged to republish and rewrite Creative Commons licensed Fight Aging! content in any way you see fit, the only requirements being that you (a) link to the original, (b) attribute the author, and (c) attribute Fight Aging!.
Good suggestion.
Since caffeine is also an AMPK agonist -
"Caffeine Enhances Endothelial Repair by an AMPK-Dependent Mechanism"
http://atvb.ahajournals.org/content/28/11/1967.full.pdf
- it may be work synergistically with rapamycin also.
Besides, caffeine also inhibits mTOR.
Would adding an nf-kappab inhibitor increase longevity even more?
Also worth noting is that metformin may promote brain health by increasing neurogenesis. See:
"Diabetes drug triggers neuron growth, potential to regenerate brain cells: study"
http://www.stemcellcafe.com/stem-cells/diabetes-drug-triggers-neuron-growth-potential-to-regenerate-brain-cells-study.php
How does does the combination of metformin with rapamycin affect metformin's efficacy as a diabetes medication?
I have been on 2000mg per day of metformin for 15 years and I do not have any problems with insulin sensitivity, although I am a type I diabetic.
Metformin reduces my insulin requirements by about 20%, which I think is
great. I started on rapamycin about a month ago, so I guess I'm in a study group of one. Heck I drink an entire pot of coffee everyday, too. I've had diabetes for 26 years without any complications, so something is working.